Loading...
Collagenase Clostridium histolyticum in the treatment of Peyronie’s disease: patient selection and perspectives
The safety and efficacy of the use of collagenase Clostridium histolyticum (CCH) for the treatment of Peyronie’s disease has been confirmed over the past several years. However, identification of the ideal patient population for use of this treatment is not well established. Multiple studies have at...
Na minha lista:
| Udgivet i: | Patient Prefer Adherence |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Dove Medical Press
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5338950/ https://ncbi.nlm.nih.gov/pubmed/28280315 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/PPA.S113507 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|